✦ LIBER ✦

1194 End of treatment and sustained response to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) (COPEGUS) and amantadine (AMA), and to induction therapy with interferon (IFN) alfa-2A (ROFERON-A) plus RBV and AMA in IFN/RBV nonresponders with chronic hepatitis C (CHC)

✍ Scribed by FARGION, S; BORZIO, M; CARGNEL, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2A (40KD) (PEGASYS) p

✍ S. Fargion; M. Borzio; A. Cargnel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 312 KB

475 Sustained virological response (SVR)

✍ S. Fargion; M. Borzio; A. Maraschi; A. Cargnel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Re-treatment of interferon (IFN) plus ri

✍ S. Brillanti; A. Mangia; L. Cimino; A. Civolani; F. Fatuzzo; L. Fenoglio; M. Lev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

1186 PEG-IFN alfa-2A (40KD) (PEGASYS) pl

✍ IDEO, G; ATTILI, A; BABUDIERI, S; CHIRIANNI, A; CRAXI, A; DIPERRI, G; FRANCAVILL 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

PEG-IFN alfa-2a (40kd) (Pegasys) plus am

✍ G. Ideo; A. Attili; G. Ruggiero; A. Craxi; G. Di Perri; A. Mangia; A. Picciotto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A randomised controlled trial on pegylat

✍ A. Mangia; G.L. Ricci; N. Minerva; M. Persico; V. Carretta; D. Bacca; M. Cela; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB